CBPO [China Biologic Products] 8-A12B:
[]
[EXECUTION COPY PREFERRED SHARES RIGHTS AGREEMENT Dated as of January 8, 2015 CHINA BIOLOGIC PRODUCTS, INC. and SECURITIES TRANSFER CORPORATION, TABLE OF CONTENTS Page Section 1. Certain Definitions 1 Section 2. Appointment of Rights Agent 9 Section 3. Issuance of Rights Certificates 9 Section 4. Form of Rights Certificates 12 Section 5. 12 Section 6. Transfer, Split Up, Combination and] [FOR RELEASE January 8, 2015 China Biologic Adopts Stockholder Rights Plan BEIJING, China – January 8, 2015 – The stockholder rights plan, which has a term of two years, is designed to guard against partial tender offers and other coercive tactics to gain control or undue influence of China Biologic without offering a fair and adequate price and terms to] []
[EXECUTION COPY PREFERRED SHARES RIGHTS AGREEMENT Dated as of January 8, 2015 CHINA BIOLOGIC PRODUCTS, INC. and SECURITIES TRANSFER CORPORATION, TABLE OF CONTENTS Page Section 1. Certain Definitions 1 Section 2. Appointment of Rights Agent 9 Section 3. Issuance of Rights Certificates 9 Section 4. Form of Rights Certificates 12 Section 5. 12 Section 6. Transfer, Split Up, Combination and] [FOR RELEASE January 8, 2015 China Biologic Adopts Stockholder Rights Plan BEIJING, China – January 8, 2015 – The stockholder rights plan, which has a term of two years, is designed to guard against partial tender offers and other coercive tactics to gain control or undue influence of China Biologic without offering a fair and adequate price and terms to] []
[650 Page Mill Road Palo Alto, CA 94304-1050 PHONE 650.493.9300 FAX 650.493.6811 www.wsgr.com December 23, 2014 VIA EDGAR AND OVERNIGHT DELIVERY Division of Corporation Finance 100 F Street, N.E. Mail Stop 4561 Attention: Mark Brunhofer Jim B. Rosenberg Re: China Biologic Products, Inc. Form 10-K for the Fiscal Year Ended December 31, 2013 Filed March 12, 2014 File No. 1-34566]
[650 Page Mill Road Palo Alto, CA 94304-1050 PHONE 650.493.9300 FAX 650.493.6811 www.wsgr.com December 23, 2014 VIA EDGAR AND OVERNIGHT DELIVERY Division of Corporation Finance 100 F Street, N.E. Mail Stop 4561 Attention: Mark Brunhofer Jim B. Rosenberg Re: China Biologic Products, Inc. Form 10-K for the Fiscal Year Ended December 31, 2013 Filed March 12, 2014 File No. 1-34566]
[SHARE PURCHASE AND TRANSFER AGREEMENT Agreement Seller Purchaser Parties Party This SHARE PURCHASE AND TRANSFER AGREEMENT, dated November 17, 2014 (“ ( Transferring Shares Company WHEREAS, Seller owns of record and beneficially an aggregate of 1,183,790 shares of common stock, par value US$0.0001 per share WHEREAS, Seller desires to sell to Purchaser, and Purchaser desires to purchase and acquire from] [Siu Ling Chan 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ (b) ¨ 3 SEC USE ONLY 4 SOURCE OF FUNDS PF 5 ¨ 6 CITIZENSHIP OR PLACE OF ORGANIZATION People’s Republic of China NUMBER OF 7 SOLE VOTING POWER [1] 1,183,791 SHARES BENEFICIALLY]
[SHARE PURCHASE AND TRANSFER AGREEMENT Agreement Seller Purchaser Parties Party This SHARE PURCHASE AND TRANSFER AGREEMENT, dated November 17, 2014 (“ ( Transferring Shares Company WHEREAS, Seller owns of record and beneficially an aggregate of 1,183,790 shares of common stock, par value US$0.0001 per share WHEREAS, Seller desires to sell to Purchaser, and Purchaser desires to purchase and acquire from] [Siu Ling Chan 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ (b) ¨ 3 SEC USE ONLY 4 SOURCE OF FUNDS PF 5 ¨ 6 CITIZENSHIP OR PLACE OF ORGANIZATION People’s Republic of China NUMBER OF 7 SOLE VOTING POWER [1] 1,183,791 SHARES BENEFICIALLY]
[CHINA BIOLOGIC PRODUCTS, INC. INDEPENDENT DIRECTOR AGREEMENT Agreement Company Joseph Chow Director THIS AGREEMENT (The “ BACKGROUND The Board of Directors of the Company desires to appoint the Director to fill an existing vacancy and to have the Director perform the duties of an independent director and the Director desires to be so appointed for such position and to perform] []
[CHINA BIOLOGIC PRODUCTS, INC. INDEPENDENT DIRECTOR AGREEMENT Agreement Company Joseph Chow Director THIS AGREEMENT (The “ BACKGROUND The Board of Directors of the Company desires to appoint the Director to fill an existing vacancy and to have the Director perform the duties of an independent director and the Director desires to be so appointed for such position and to perform] []
[FOR RELEASE November 5, 2014 China Biologic Reports Financial Results for the Third Quarter and First Nine Months of 2014 --3Q14 Total Sales Up 29.5% to $68.9 Million / 9M Total Sales Up 15.2% to $185.3 Million-- --3Q14 Operating Margin Up 660 bp to 50.2% / 9M Operating Margin Up to 49.4% -- --3Q14 Non-GAAP Net Income Up 36.8% /] []